Short-term surgical morbidity and mortality of distal pancreatectomy performed for benign versus malignant diseases: a NSQIP analysis

dc.contributor.authorDaniel, Fady E.
dc.contributor.authorTamim, Hani Mohammed
dc.contributor.authorHosni, Mohammad N.
dc.contributor.authorMailhac, Aurélie C.
dc.contributor.authorKhalife, Mohamad Jawad
dc.contributor.authorJamali, Faek R.
dc.contributor.authorFaraj, Walid G.
dc.contributor.departmentInternal Medicine
dc.contributor.departmentClinical Research Institute
dc.contributor.departmentSurgery
dc.contributor.departmentBiostatistics Unit (BSU)
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:57:31Z
dc.date.available2025-01-24T11:57:31Z
dc.date.issued2020
dc.description.abstractBackground/aim: Distal pancreatectomy (DP) accounts for 25% of all pancreatic resections. Complications following DP occur in around 40% of the cases. Our aim is to analyze short-term surgical outcomes of DP based on whether the indication for resection was benign or malignant pathology, as well as the effect of the surgical approach, open versus laparoscopic on morbidity and mortality. Methods: We studied all patients undergoing DP from the National Surgery Quality Improvement Program (NSQIP) targeted pancreatectomy participant use file from 2014 to 2016. The patients were divided into 2 groups, those who underwent DP for benign diseases (DP-B) and those who underwent DP for malignant diseases (DP-M). We performed multivariate logistic regression to evaluate the association between benign or malignant distal pancreatectomies and 30-day outcomes. We included clinically and/or statistically significant confounders into the models. We also conducted the same analysis in the subgroups of open and laparoscopic DP. Results: Three thousand five hundred and seventy-nine patients underwent distal pancreatectomy. The most common indication for surgery was malignant disease in 1894 (53%). Thirty-day mortality occurred in 0.4% of DP-B compared to 1.3% DP-M. On multivariate analysis, no significant difference was found in mortality or in the risk of pancreatic fistula between the 2 groups. Bleeding (p = 0.002) and composite morbidity (p = 0.01) were significantly higher in the DP-M group. Among composite morbidities, thromboembolism was significantly associated with DP-M (OR 2.1, p = 0.0004) only when performed with an open approach. Conclusion: DP-M is associated with a significantly higher risk of post-operative bleeding, thromboembolism, and sepsis compared to DP-B but no significant increase in mortality. When further analyzing the impact of the operative approach on morbidity, there was an increased rate of post-operative thromboembolic in the DP-M group when the surgery was performed in an open manner and this increased risk was no longer statistically significant if the DP-M was performed using a minimally invasive approach. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.
dc.identifier.doihttps://doi.org/10.1007/s00464-019-07163-5
dc.identifier.eid2-s2.0-85074054956
dc.identifier.pmid31598880
dc.identifier.urihttp://hdl.handle.net/10938/31297
dc.language.isoen
dc.publisherSpringer
dc.relation.ispartofSurgical Endoscopy
dc.sourceScopus
dc.subjectDistal pancreatectomy
dc.subjectLaparoscopy
dc.subjectPancreatic neoplasms
dc.subjectThromboembolism
dc.subjectAged
dc.subjectFemale
dc.subjectHumans
dc.subjectLogistic models
dc.subjectMale
dc.subjectMiddle aged
dc.subjectMorbidity
dc.subjectPancreatectomy
dc.subjectPostoperative complications
dc.subjectQuality improvement
dc.subjectTreatment outcome
dc.subjectAdult
dc.subjectArticle
dc.subjectCancer surgery
dc.subjectChronic pancreatitis
dc.subjectClinical evaluation
dc.subjectClinical outcome
dc.subjectCohort analysis
dc.subjectCystadenocarcinoma
dc.subjectCystadenoma
dc.subjectHeart injury
dc.subjectHuman
dc.subjectIncidence
dc.subjectIntermethod comparison
dc.subjectIntraductal papillary mucinous tumor
dc.subjectLaparoscopic distal pancreatectomy
dc.subjectMajor clinical study
dc.subjectMucinous cystic neoplasm
dc.subjectNeuroendocrine tumor
dc.subjectOpen distal pancreatectomy
dc.subjectOpen surgery
dc.subjectPancreas adenocarcinoma
dc.subjectPancreas fistula
dc.subjectPostoperative hemorrhage
dc.subjectPriority journal
dc.subjectRegister
dc.subjectRespiratory tract injury
dc.subjectRetrospective study
dc.subjectReturn to operating room
dc.subjectSepsis
dc.subjectSolid pseudopapillary tumor
dc.subjectStomach paresis
dc.subjectSurgical mortality
dc.subjectSurgical patient
dc.subjectSurgical risk
dc.subjectUrinary tract injury
dc.subjectWound complication
dc.subjectAdverse event
dc.subjectComparative study
dc.subjectMortality
dc.subjectPancreas tumor
dc.subjectPostoperative complication
dc.subjectStatistical model
dc.subjectTotal quality management
dc.titleShort-term surgical morbidity and mortality of distal pancreatectomy performed for benign versus malignant diseases: a NSQIP analysis
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2020-3136.pdf
Size:
566.16 KB
Format:
Adobe Portable Document Format